Boosting BNT162b2 vaccine efficacy in CLL. | Blood;139(5): 639-640, 2022 02 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Boosting BNT162b2 vaccine efficacy in CLL.

Bhat, Seema A; Woyach, Jennifer A.

Bhat SA; The Ohio State University Comprehensive Cancer Center.
Woyach JA; The Ohio State University Comprehensive Cancer Center.

Blood ; 139(5): 639-640, 2022 02 03.

Article in English | MEDLINE | ID: covidwho-1664129

Subject(s)

COVID-19; Leukemia, Lymphocytic, Chronic, B-Cell; BNT162 Vaccine; COVID-19 Vaccines; Humans; Vaccine Efficacy

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Blood Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Blood Year: 2022 Document Type: Article